ホームページへ
4.6/5
TrustPilot

イタリアで最高の平滑筋肉腫切除術医師 - トップ1名の医師

イタリアのトップ平滑筋肉腫切除術医師と価格を比較。こちらで最適なマッチングを見つけてください

イタリアの3名のトップ平滑筋肉腫切除術専門家から見積もりを取得

ご要望と予算に基づいて最適な医師を厳選いたします

トップ医師

1

イタリア

レビュー

14000+

実際の患者より

個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし

Arnaldo Filippini

  • 新着
  • 46年の経験
  • 所在地: イタリア, ボローニャ
  • クリニック:Maria Cecilia Hospital
  • Prof. Filippini began his career in 1980 and has been teaching at the University of Chieti since the 1990s in the fields of General Surgery, Microsurgery, Reconstructive Surgery, Vascular Surgery, Orthopedics, and Gynecology. His primary focus is oncological surgery, particularly specializing in "The surgical treatment of locally advanced tumors and multi-organ resections." He has enriched his expertise by visiting prominent reference centers in the United States, including the Memorial Sloan Kettering Cancer Center in Manhattan, New York City. There, he delved into minimally invasive, laparoscopic, and microsurgical techniques under the guidance of esteemed mentors such as John Daly, Michele Gagner, and Murray Brennan. Additionally, in 2005, he further expanded his skills at the City of Hope Oncology Center in Los Angeles, focusing on robotic surgery in oncology.

    In 1980, Prof. Filippini graduated in Medicine and Surgery from the G. D'Annunzio University of Chieti in Italy with honors, presenting an experimental thesis on lympho-venous anastomosis using microsurgical techniques. He completed his specialization in general surgery at the University of Pisa with distinction after five years. In 1990, he obtained another specialization in Plastic and Reconstructive Surgery from the University of Padua in Italy, where he maintained a stellar academic record.

    Prof. Filippini has presented at numerous national and international conferences and authored over 100 scientific publications. Additionally, he has co-authored two monographs. 

  • 続きを読む
診察
お問い合わせください

海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。

ヤン・マツィイフスキー

医療コーディネーターチーム責任者

4300+件以上の患者の旅をガイド

Bookimedで3

Italyの294名の患者が今月当社を通じて医師を見つけました

完璧な医師マッチングを取得する方法

1

2分のクイズ

目標、予算、スケジュールをお聞かせください

2

人間のマッチング + AI

アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します

3

オプション準備完了

価格、パッケージ、日程を比較。コーディネーターとチャット

選択肢に迷っていますか?

専属の Bookimedコーディネーターがお客様のニーズに合わせた完璧な外科医を見つけるお手伝いをします

  • すべての段階で24時間365日サポート
  • 医師とのマッチングサポートとクリニックとの全てのコミュニケーションを処理
  • 旅行、宿泊、送迎を調整します

治療をガイド

医療訓練を受けた専属コーディネーター

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

適切な医師とクリニックの選び方:内部者のヒント

医師やクリニックを選ぶ際は、これらの重要なポイントを覚えておいてください:
資格を確認
ISAPS、JCI、または関連医学会などの機関からの認証を確認してください
成功率を確認
お客様の特定治療に豊富な経験と実績のある医師をお選びください
患者レビューを読む
実際の患者様のBookimedレビューをご覧になり、体験について学んでください
効果的なコミュニケーションの確保
円滑な治療のため言語サポートを提供するクリニックを選んでください。
サービスについて質問
隠れた費用を避けるため、価格に宿泊、現地送迎、アフターケアなどのサービスが含まれているかご確認ください

Bookimed洞察:イタリアのトップ平滑筋肉腫切除術専門家(2026)

Bookimedはイタリアの平滑筋肉腫切除術リクエスト53672件を調整し、1名のトップ評価専門家と協力しています。この表の医師は国際的資格、臨床専門知識、患者の結果に基づいて選ばれています。2026年ランキングは実際の患者ケースとパートナークリニックの現行プログラムからの検証済みデータを使用して形成されています
順位医師経験適合する方特色クリニックと所在地診察

FAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

What are the top-rated clinics for leiomyosarcoma removal in Italy?

Italy hosts world-class oncology hubs specializing in leiomyosarcoma removal, particularly within Milan's dense medical corridor. Top-rated facilities like Istituto Nazionale dei Tumori and the European Institute of Oncology (IEO) lead the way in surgical volume, multidisciplinary rare tumor care, and robotic-assisted tumor resection.

  • Istituto Nazionale dei Tumori: Major referral hub specializing in complex surgical resections for rare soft tissue sarcomas.
  • European Institute of Oncology: Specialized Surgical Division of Melanoma and Sarcoma focusing on high-volume oncology research.
  • Ospedale San Carlo di Nancy: Rome-based hospital recognized for its 5-star rating and advanced Da Vinci robotic systems.
  • Istituto Ortopedico Rizzoli: National reference center in Bologna for specialized musculoskeletal and soft tissue sarcoma treatment.

Bookimed Expert Insight: While Milan is the primary sarcoma hub, surgeons like Prof. Arnaldo Filippini at Maria Cecilia Hospital bring elite US-based training from Memorial Sloan Kettering to Italy. This creates a high-quality alternative for multi-organ resections outside the busiest Milanese centers.

Patient Consensus: Seeking centers handling over 50 cases yearly is vital for success. Many recommend northern hubs like Milan over Rome for complex pelvic leiomyosarcoma care.

What is the standard surgical approach for leiomyosarcoma in Italy?

Standard surgical treatment for leiomyosarcoma in Italy focuses on radical en bloc resection with negative margins. Italian guidelines prioritize treatment at specialized sarcoma referral centers. For uterine cases, total abdominal hysterectomy is the gold standard without morcellation. Soft tissue cases require wide local excision with clear margins.

  • Resection protocol: Surgeons aim for R0 margins with at least 1 cm of healthy tissue.
  • Uterine standards: Protocols require total hysterectomy while avoiding any form of tumor morcellation.
  • Limb preservation: Modern Italian practice focuses on limb-sparing surgery paired with perioperative radiotherapy.
  • Retroperitoneal approach: Doctors perform en bloc resection of the tumor and adjacent involved organs.

Bookimed Expert Insight: Italian surgical expertise often combines oncological resection with advanced reconstruction. Surgeons like Prof. Arnaldo Filippini at Maria Cecilia Hospital bring specialized training from Memorial Sloan Kettering to Italy. This international training influence means patients often access multi-organ resection techniques and microsurgery. These advanced approaches are vital for complex tumors in the retroperitoneum where organ involvement is high.

Patient Consensus: Patients emphasize the importance of contacting major oncology institutes in Rome or Milan directly. Many suggest seeking a second opinion within European networks to verify specific multimodal treatment protocols.

What 5-year survival rates can patients expect after complete surgery?

Patients undergoing complete leiomyosarcoma removal in Italy can expect a 5-year survival rate of approximately 60% to 75% for localized tumors. Survival heavily depends on tumor size, grade, and achieving clear margins during resection by experienced oncological surgeons using advanced surgical techniques.

  • Success factor: Achieving clear margins significantly increases long-term survival rates after tumor removal.
  • High-tech tools: Italian centers like Ospedale San Carlo di Nancy utilize Da Vinci robotic systems.
  • Specialized expertise: Surgeons like Prof. Arnaldo Filippini focus on complex multi-organ resections for advanced sarcoma.
  • Accreditation: Top Italian facilities operate under the Italian National Health Service and GVM Care Research.

Bookimed Expert Insight: Italian surgical expertise in sarcomas often links to multidisciplinary centers that combine reconstruction with removal. Prof. Arnaldo Filippini at Maria Cecilia Hospital trained at Memorial Sloan Kettering, bringing high-volume US experience to Italy. This specific focus on microsurgical and reconstructive techniques allows for more aggressive tumor removal while preserving patient function.

How is recurrence surveillance managed after leiomyosarcoma surgery in Italy?

Recurrence surveillance in Italy follows European Society for Medical Oncology (ESMO) protocols at specialized sarcoma centers. High-grade leiomyosarcoma requires clinical visits and CT scans every 3–4 months for 3 years. Frequency transitions to every 6 months until year 5, followed by lifelong annual monitoring for late recurrences.

  • Imaging standards: CT scans of chest, abdomen, and pelvis remain the primary monitoring tool.
  • Risk-based scheduling: Low-grade tumors require less frequent checks, typically every 4–6 months initially.
  • Specialized sites: Uterine leiomyosarcoma surveillance often integrates pelvic MRI or ultrasound for early detection.
  • Multidisciplinary oversight: Tumor boards including surgical oncologists and radiologists coordinate long-term surveillance plans.

Bookimed Expert Insight: While local clinics offer standard scans, Italian sarcoma hubs like those in Rome or Milan prioritize multi-organ resection expertise. Surgeons like Prof. Arnaldo Filippini at Maria Cecilia Hospital bring experience from Memorial Sloan Kettering to manage complex recurrences. Patients should ensure their surveillance plan includes specialized imaging for retroperitoneal sites where recurrence is harder to detect.

Patient Consensus: Survivors emphasize tracking vague symptoms like fatigue or localized pain between scheduled scans. Many recommend using a symptoms app to provide data that might trigger earlier imaging if needed.

Are minimally invasive or robotic options used for leiomyosarcoma surgery in Italy?

Italian oncology centers utilize robotic and minimally invasive techniques for localized leiomyosarcoma cases in high-volume referral centers. While open surgery remains the standard for large tumors, surgeons leverage Da Vinci robotic platforms and advanced laparoscopy for small, encapsulated tumors near major blood vessels or the retroperitoneum.

  • Robotic precision: Da Vinci systems provide 3D visualization for tumors near the aorta or vena cava.
  • Selection criteria: Minimally invasive approaches are reserved for small tumors to ensure wide surgical margins.
  • Safety protocols: Italian guidelines strictly avoid power morcellation to prevent malignant cell seeding and spillage.
  • Specialized expertise: Top centers focus on R0 resection, ensuring complete removal with pathologically clean edges.

Bookimed Expert Insight: Data shows a high concentration of advanced technology in Rome and Ravenna. Clinics like Ospedale San Carlo di Nancy specialize in robotic systems, while experts like Prof. Arnaldo Filippini at Maria Cecilia Hospital bring international training from Memorial Sloan Kettering. This creates a unique environment where robotic dexterity meets multi-organ resection expertise.

Patient Consensus: Patients emphasize that while robotics are appealing, open surgery is often chosen for tumors larger than 10cm. They recommend prioritizing centers with specific sarcoma expertise to ensure long-term margin status and lower recurrence.